Clinical Trials Logo
  1. Home
  2. Neoplasms, Prostate
  3. NCT02652000

Quality of Life After Permanent Interstitial Iodine Seed Prostate Brachytherapy

Neoplasms, Prostate Clinical Trial

Official title:
Retrospective Analysis of Quality of Life After Permanent Interstitial Iodine Seed Brachytherapy for Prostate Cancer

Clinical Trial Summary

Retrospective study to analyze Quality of life in men after iodine seed brachytherapy for localized prostate cancer

Clinical Trial Description

Retrospective Evaluation of Quality of life data collected on men who underwent iodine seed brachytherapy at the University Hospital Zurich ;

Study Design

Time Perspective: Retrospective

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02652000
Study type Observational
Source Kantonsspital Graubuenden
Contact
Status Completed
Phase N/A
Start date October 2009
Completion date December 2016
View Details
See also
  Status Clinical Trial Phase
Completed NCT00970203 - Dendritic Cell (DC)-Based Vaccines Loaded With Allogeneic Prostate Cell Lines in Combination With Androgen Ablation in Patients With Prostate Cancer Phase 2
Completed NCT00558363 - ARTS - AVODART After Radical Therapy For Prostate Cancer Study Phase 2
Completed NCT02153918 - Vaccine Plus Booster Shots in Men With Prostate Cancer Undergoing Treatment With Radical Prostatectomy Phase 2
Completed NCT01371513 - Korean Practice Patterns for Screening PCA(Prostate Cancer) N/A
Completed NCT00470834 - Prostate Cancer Study In Men Who Have Failed First-Line Androgen Deprivation Therapy Phase 4
Completed NCT00056407 - "REDUCE" - A Clinical Research Study To Reduce The Incidence Of Prostate Cancer In Men Who Are At Increased Risk Phase 3
Completed NCT00148928 - Safety & Activity of P501-AS15 Vaccine as a First-line Treatment for Patients With Hormone-sensitive Prostate Cancer Who Show Rising PSA Phase 1
Completed NCT01477749 - Sipuleucel-T Manufacturing Demonstration Study Phase 2
Completed NCT00363311 - Assessment Of Dutasteride (AVODART) In Extending The Time To Progression Of Low-Risk, Localized Prostate Cancer In Men Phase 4
Completed NCT01337258 - Economic Analyses of the REDUCE Trial N/A
Terminated NCT02349139 - Safety, Preliminary Efficacy and Pharmacokinetics of ASN001 in Metastatic Castrate Resistant Prostate Cancer Phase 1
Active, not recruiting NCT04249947 - P-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Advanced Salivary Gland Cancers (SGC) Phase 1
Completed NCT00883909 - ARI103094-Follow-Up Study for REDUCE Study Subjects N/A